Efficacy of Favipiravir in Adults with Mild COVID-19: a Randomized, Double-Blind, Multicentre, Placebo-Controlled Clinical Trial
Mohammad Bosaeed,Ahmad Alharbi,Ebrahim Mahmoud, Sanaa Alrehily, Mohannad Bahlaq,Zied Gaifer,Hanan Alturkistani,Khaled Alhagan,Saad Alshahrani, Ali Tolbah,Abrar Musattat,Maha Alanazi,Raniah Jaha,Khizra Sultana,Hajar Alqahtani,Kholoud Al Aamer, Saud Jaser,Abdulrahman Alsaedy, Ayoub Ahmad,Mohammed Abalkhail,Sameera AlJohani,Majed Al Jeraisy,Sultan Almaziad, Nahlah Albaalharith,Khaled Alabdulkareem,Abdulmajeed Alshowair,Naif Khalaf Alharbi,Fahad Alrabiah,Majid Alshamrani,Omar Aldibasi,Ahmed Alaskar CLINICAL MICROBIOLOGY AND INFECTION（2022）
Key words
Clinical trial,Favipiravir,Mild COVID-19,Non-severe SARS-CoV-2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper